Monday, 30 September 2019

AstraZeneca, Merck ovarian cancer treatment improves progression-free survival

AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)